The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?
Top Cited Papers
- 30 November 2009
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 14 (21-22), 1011-1020
- https://doi.org/10.1016/j.drudis.2009.07.014
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Physiochemical drug properties associated with in vivo toxicological outcomesBioorganic & Medicinal Chemistry Letters, 2008
- Straightforward Recursive Partitioning Model for Discarding Insoluble Compounds in the Drug Discovery ProcessJournal of Medicinal Chemistry, 2008
- From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonistsBioorganic & Medicinal Chemistry Letters, 2008
- From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: The discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxisBioorganic & Medicinal Chemistry Letters, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Properties Guiding Drug‐ and Lead‐LikenessPublished by Wiley ,2007
- Time-Related Differences in the Physical Property Profiles of Oral DrugsJournal of Medicinal Chemistry, 2004
- A Comparison of Physiochemical Property Profiles of Development and Marketed Oral DrugsJournal of Medicinal Chemistry, 2003
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug DiscoveryJournal of Chemical Information and Computer Sciences, 2001